Rheumatology · Anti-TNFα monoclonal antibody
Adalimumab
Dose
40 mg SC every 2 weeks (loading regimens differ in IBD).
Contraindications
- • Active infection or untreated latent TB
- • NYHA III–IV heart failure
- • Demyelinating disease
Use
RA, psoriatic arthritis, ankylosing spondylitis, Crohn's, ulcerative colitis, uveitis.
Monitoring
Screen for latent TB, hepatitis B/C, HIV before starting; watch for infection and demyelination.
Side effects
- • Injection-site reactions
- • Serious/opportunistic infection
- • TB reactivation
- • Drug-induced lupus
Always confirm dose against your local formulary / BNF before prescribing.
